
MI-223
CAS No. 907166-59-0
MI-223( NSC 320223 )
Catalog No. M16518 CAS No. 907166-59-0
MI-223 (NSC 320223) is a small molecule that specifically binds to Mcl-1 with Kd of 160 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
![]() ![]() |
50MG | 1782 | Get Quote |
![]() ![]() |
100MG | 2250 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameMI-223
-
NoteResearch use only, not for human use.
-
Brief DescriptionMI-223 (NSC 320223) is a small molecule that specifically binds to Mcl-1 with Kd of 160 nM.
-
DescriptionMI-223 (NSC 320223) is a small molecule that specifically binds to Mcl-1 with Kd of 160 nM, inhibits HR DNA repair and sensitizes cancer cells to DNA replication agents; not only disrupts the Mcl-1/Ku complex, but also potently inhibits HR activity in both H1299 and U2OS DR-GFP cells in a dose-dependent manner, sensitizes cancer cells to hydroxyurea- or olaparib-induced DNA replication stress; exhibits a strong synergy against lung cancer in vivo combined with Olaparib.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 320223
-
PathwayAngiogenesis
-
TargetBcl-2
-
RecptorBcl-2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number907166-59-0
-
Formula Weight419.865
-
Molecular FormulaC23H18ClN3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1N(/N=C/C2=CC=CC(OCC)=C2O)C(C3=CC=CC=C3Cl)=NC4=C1C=CC=C4
-
Chemical Name2-(2-chlorophenyl)-3-[[(Z)-(5-ethoxy-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]amino]quinazolin-4-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chen G, et al. J Clin Invest. 2018 Jan 2;128(1):500-516.
molnova catalog



related products
-
SW076956
SW076956 is a small molecule that selectively disrupt Beclin 1/Bcl-2 binding as compared to Bax/Bcl-2 and Bim/Bcl-2 binding and induces autophagic flux at concentrations with minimal cytotoxicity.
-
CID5721353
BCL6 inhibitor 79-6 (Compound 79-6) is the first-generation, specific BCL6 BTB domain inhibitor with IC50 of 200 uM, Kd of 129 uM.
-
Navitoclax-piperazin...
Navitoclax-piperazine is an inhibitor of B-cell lymphoma extra large (BCL-XL).